Literature DB >> 14647252

Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.

A E Mitchell1, P Derrington, P Turner, L P Hunt, A Oakhill, D I Marks.   

Abstract

Gram-negative infection is an important cause of morbidity and mortality after unrelated donor-bone marrow transplantation (UD-BMT). We performed a retrospective case-control study to examine the risk factors, prophylaxis, therapy and outcome of Gram-negative bacteraemia (GNB) in 428 patients undergoing UD-BMT. The incidence of GNB was 3.6% in children and 19% in adults. Of the adults, 11% developed GNB >60 days post UD-BMT. Predisposing risk factors for GNB included 'high-risk' disease status, chronic graft-versus-host disease and use of systemic steroids. Fever, a raised C-reactive protein (CRP) and hypotension were common findings at presentation. Patients were routinely given prophylactic ciprofloxacin: resistance to this antibiotic was seen in 33% of isolates. We identified an age-matched control group undergoing UD-BMT over the same time period as the study group. Gram-positive bacteraemia was significantly more common in cases than controls. Mortality from GNB was 17% in children and 24% in adults. We conclude that GNB is a common complication of UD-BMT with a high associated mortality. Patients should be educated further to present rapidly with symptoms suggestive of infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14647252     DOI: 10.1038/sj.bmt.1704338

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.

Authors:  Takayoshi Tachibana; Masatsugu Tanaka; Hirotaka Takasaki; Ayumi Numata; Satomi Ito; Reina Watanabe; Rie Hyo; Rika Ohshima; Maki Hagihara; Rika Sakai; Shin Fujisawa; Naoto Tomita; Hiroyuki Fujita; Atsuo Maruta; Yoshiaki Ishigatsubo; Heiwa Kanamori
Journal:  Int J Hematol       Date:  2011-02-18       Impact factor: 2.490

2.  Profile and Antibiotic Pattern of Blood Stream Infections of Patients Receiving Hematopoietic Stem Cell Transplants in Southwest China.

Authors:  Qiang Zeng; Bing Xiang; Zhigang Liu
Journal:  Infect Drug Resist       Date:  2022-04-21       Impact factor: 4.177

3.  Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.

Authors:  C Gudiol; C Garcia-Vidal; M Arnan; I Sánchez-Ortega; B Patiño; R Duarte; J Carratalà
Journal:  Bone Marrow Transplant       Date:  2014-03-24       Impact factor: 5.483

4.  Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation.

Authors:  Jason W Chien; Michael J Boeckh; John A Hansen; Joan G Clark
Journal:  Blood       Date:  2007-12-03       Impact factor: 22.113

Review 5.  Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.

Authors:  C E Dandoy; M I Ardura; G A Papanicolaou; J J Auletta
Journal:  Bone Marrow Transplant       Date:  2017-03-27       Impact factor: 5.174

6.  Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections.

Authors:  Masahiro Hirayama; Eiichi Azuma; Yoshihiro Komada
Journal:  Cells       Date:  2012-04-30       Impact factor: 6.600

7.  Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation.

Authors:  Celalettin Ustun; Jo-Anne H Young; Genovefa A Papanicolaou; Soyoung Kim; Kwang Woo Ahn; Min Chen; Hisham Abdel-Azim; Mahmoud Aljurf; Amer Beitinjaneh; Valerie Brown; Jan Cerny; Saurabh Chhabra; Mohamed A Kharfan-Dabaja; Parastoo B Dahi; Andrew Daly; Christopher E Dandoy; Christopher C Dvorak; Cesar O Freytes; Shahrukh Hashmi; Hillard Lazarus; Per Ljungman; Taiga Nishihori; Kristin Page; Sai R K Pingali; Ayman Saad; Bipin N Savani; Daniel Weisdorf; Kirsten Williams; Baldeep Wirk; Jeffery J Auletta; Caroline A Lindemans; Krishna Komanduri; Marcie Riches
Journal:  Bone Marrow Transplant       Date:  2018-12-13       Impact factor: 5.483

8.  Bacteremia in Hematopoietic Stem Cell Recipients Receiving Fluoroquinolone Prophylaxis: Incidence, Resistance, and Risk Factors.

Authors:  Esma Eryilmaz-Eren; Feyza Izci; Zeynep Ture; Pinar Sagiroglu; Leylagul Kaynar; Aysegul Ulu-Kilic
Journal:  Infect Chemother       Date:  2022-07-29

9.  The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients.

Authors:  Mücahit Yemişen; İlker İnanç Balkan; Ayşe Salihoğlu; Ahmet Emre Eşkazan; Bilgül Mete; M Cem Ar; Şeniz Öngören; Zafer Başlar; Reşat Özaras; Neşe Saltoğlu; Ali Mert; Burhan Ferhanoğlu; Recep Öztürk; Fehmi Tabak; Teoman Soysal
Journal:  Turk J Haematol       Date:  2015-05-04       Impact factor: 1.831

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.